Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as Zydus) has received final approval from the United States Food and Drug Administration (USFDA) to market Dapsone Gel, 7.5%, (USRLD : Aczone® Gel 7.5%). 

Dapsone Gel is used to treat acne and will be manufactured at the group’s topical manufacturing facility at Changodar, Ahmedabad (India). 

Dapsone Gel, 7.5% had annual sales of USD 35.8 mn in the United States (IQVIA MAT March 24).

 The Centre for Cellular and Molecular Platforms (C-CAMP) and Blockchain for Impact (BFI) have partnered under the aegis of the BFI-Biome Virtual Network Program to help nurture talented innovators and support the development of indigenous, cost-effective solutions. This program aims to improve public health and healthcare access in India.

Zoetis is a global animal health company dedicated to supporting customers and their businesses. Building on more than 60 years of experience, we deliver quality medicines, biopharmaceuticals and vaccines, complemented by diagnostic products and genetic tests and supported by a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.

Post : Scientist / Senior Scientist (ARD) (06052024)